Voya Investment Management LLC Cerevel Therapeutics Holdings, Inc. Transaction History

Voya Investment Management LLC

  • $78.9 Billion
  • Q4 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Feb 07, 2025
BUY
$38.96 - $42.75 $443,754 - $486,922
11,390 Added 49.91%
34,210 $1.4 Million
Q2 2024

Dec 03, 2024
BUY
$38.96 - $42.75 $1.33 Million - $1.46 Million
34,210 New
34,210 $1.4 Million
Q2 2024

Aug 14, 2024
BUY
$38.96 - $42.75 $443,754 - $486,922
11,390 Added 49.91%
34,210 $1.4 Million
Q1 2024

Feb 07, 2025
BUY
$40.88 - $43.27 $932,881 - $987,421
22,820 New
22,820 $964,000
Q1 2024

Dec 06, 2024
BUY
$40.88 - $43.27 $932,881 - $987,421
22,820 New
22,820 $964,000
Q1 2024

May 15, 2024
SELL
$40.88 - $43.27 $1.69 Million - $1.78 Million
-41,224 Reduced 64.37%
22,820 $964,000
Q4 2023

Feb 07, 2025
BUY
$20.27 - $42.44 $796,996 - $1.67 Million
39,319 Added 159.03%
64,044 $2.72 Million
Q4 2023

Feb 14, 2024
BUY
$20.27 - $42.44 $796,996 - $1.67 Million
39,319 Added 159.03%
64,044 $2.72 Million
Q3 2023

Feb 07, 2025
BUY
$20.26 - $31.91 $5,348 - $8,424
264 Added 1.08%
24,725 $539,000
Q3 2023

Nov 14, 2023
BUY
$20.26 - $31.91 $5,348 - $8,424
264 Added 1.08%
24,725 $539,000
Q2 2023

Feb 07, 2025
BUY
$23.9 - $35.38 $71,269 - $105,503
2,982 Added 13.88%
24,461 $777,000
Q2 2023

Aug 14, 2023
BUY
$23.9 - $35.38 $71,269 - $105,503
2,982 Added 13.88%
24,461 $777,000
Q1 2023

Feb 07, 2025
BUY
$22.82 - $35.32 $490,150 - $758,638
21,479 New
21,479 $523,000
Q4 2022

Feb 07, 2025
BUY
$25.35 - $31.96 $12,852 - $16,203
507 Added 2.42%
21,479 $677,000
Q4 2022

Feb 14, 2023
BUY
$25.35 - $31.96 $12,852 - $16,203
507 Added 2.42%
21,479 $677,000
Q3 2022

Feb 07, 2025
BUY
$25.5 - $41.42 $534,786 - $868,660
20,972 New
20,972 $592,000
Q3 2022

Mar 03, 2023
SELL
$25.5 - $41.42 $12,928 - $20,999
-507 Reduced 2.36%
20,972 $592,000
Q3 2022

Nov 14, 2022
BUY
$25.5 - $41.42 $12,648 - $20,544
496 Added 2.42%
20,972 $593,000
Q2 2022

Aug 15, 2022
BUY
$20.62 - $37.15 $86,067 - $155,064
4,174 Added 25.6%
20,476 $541,000
Q1 2022

May 16, 2022
BUY
$23.5 - $35.38 $13,935 - $20,980
593 Added 3.77%
16,302 $571,000
Q4 2021

Feb 14, 2022
BUY
$29.21 - $44.64 $10,077 - $15,400
345 Added 2.25%
15,709 $509,000
Q3 2021

Nov 15, 2021
BUY
$21.26 - $38.85 $28,530 - $52,136
1,342 Added 9.57%
15,364 $453,000
Q2 2021

Aug 16, 2021
BUY
$12.56 - $29.69 $176,116 - $416,313
14,022 New
14,022 $359,000

Others Institutions Holding CERE

# of Institutions
7
Shares Held
5.01M
Call Options Held
3.3K
Put Options Held
0
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email